Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis.
D000818:Animals; D016861:Cyclooxygenase Inhibitors; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D005480:Flurbiprofen / Q000008:administration & dosage*; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D008558:Melphalan / Q000008:administration & dosage*; D008727:Methotrexate / Q000008:administration & dosage*; D051379:Mice; D011422:Propionates / Q000008:administration & dosage*
D016861:Cyclooxygenase Inhibitors; D011422:Propionates; D005480:Flurbiprofen; D008558:Melphalan; D008727:Methotrexate